Results 191 to 200 of about 592,213 (353)
Abstract Machine learning (ML) and generative artificial intelligence (GAI) in recent years are rapidly revolutionizing the healthcare industry offering improved precision and efficiency of healthcare delivery. The use of these advanced technologies in healthcare such as medical imaging, drug discoveries, predictive analytics, and personalized medicine
Muhammad Umar +10 more
wiley +1 more source
Depression and anxiety in inflammatory bowel disease: mechanisms and emerging therapeutics targeting the microbiota-gut-brain axis. [PDF]
Qian Y +5 more
europepmc +1 more source
Perioperative utilization of JAK inhibitors in Perianal Fistulizing Crohn's disease
Abstract With the recent approval of small molecule drugs such as upadacitinib in adult inflammatory bowel disease (IBD), their utilization is becoming more common; however, there is limited data on perioperative risks or optimal timing of cessation and resumption to mitigate flares. Current recommendations suggest holding these medications for 14 days
Alexander Lyons +2 more
wiley +1 more source
Metabotropic glutamate receptors: Allosteric structural modulation and new treatments for anxiety disorders. [PDF]
Zakari MO.
europepmc +1 more source
ABSTRACT Background Psoriasis is a chronic inflammatory dermatological condition associated with an elevated risk of cardiovascular events (CVEs). Systemic therapies have transformed disease management, but their cardiovascular (CV) safety profiles remain incompletely understood and inconsistently reported.
Mai Thi Hoai Son +10 more
wiley +1 more source
Low resilience in patients with cancer as a factor influencing anxiety, depression, and quality-of-life. [PDF]
Li JB, Rong W.
europepmc +1 more source
Sciatic Nerve Stimulation Mitigates Depression‐Like Behaviors and Memory Deficits in Stressed Mice
ABSTRACT Stress causes depression and cognitive decline. With limitations in pharmacotherapy, sciatic nerve stimulation (SNS) offers a promising nondrug alternative. This study aimed to explore the therapeutic efficacy of SNS in mitigating stress‐induced depressive behaviors and memory deficits by focusing on astrocytic dysfunction and cellular ...
Chih‐Hao Tien +10 more
wiley +1 more source
Emerging Therapeutics in COPD: Mapping Innovation to Treatable Traits. [PDF]
Cazzola M +4 more
europepmc +1 more source
NAD+ Enhanced on Hearing Recovery in Sudden Sensorineural Hearing Loss: Randomized Controlled Trial
This 2‐year, single‐center, double‐blind study with a small sample size compared NAD+ and control groups in a randomized controlled trial for sudden sensorineural hearing loss (SSNHL). Results showed that NAD+ led to better hearing improvement from 7 days to 3 months and a shorter average recovery time compared to the control group.
Minqian Gao +7 more
wiley +1 more source

